The use of inflammatory markers (IMs) in the pediatric emergency department (PED) is broad and non-specific. This retrospective, cross-sectional study of children aged 3 months to 18 years evaluated the use of IMs in the PED. The reasons for IM use were provider practice (38%), ruling out a differential diagnosis (36%), and presence of comorbidities (18%). IMs are commonly used for gastroenterology, infectious diseases, and orthopedic diseases. A third had IMs without an indication. Forty-six percent of IM testing was indicated based on medical documentation, of which only 21% had abnormal IMs. Compared to the abnormal IM values by the on-site laboratory, the IM assessment using a receiver operating characteristic (ROC) curve threshold criterion had improved specificity and negative predictive value (NPV) based on the reason for IM use. This study suggests that the rate of abnormal IMs is low and does not affect patient outcomes in the PED.
BedellSEBushBT.Erythrocyte sedimentation rate. From folklore to facts. Am J Med. 1985;78(6):1001-1009. doi:10.1016/0002-9343(85)90224-4.
4.
KainthMKGigliottiF.Simultaneous testing of erythrocyte sedimentation rate and C-reactive protein: increased expenditure without demonstrable benefit. J Pediatr. 2014;165(3):625-627. doi:10.1016/j.jpeds.2014.05.026.
5.
BatlivalaSP.Focus on diagnosis: the erythrocyte sedimentation rate and the C-reactive protein test. Pediatr Rev. 2009;30(2):72-74. doi:10.1542/pir.30.2.72.
6.
BarnesBHBorowitzSMSaulsburyFTHellemsMSutphenJL.Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. J Pediatr Gastroenterol Nutr. 2004;38(5):509-512. doi:10.1097/00005176-200405000-00009.
7.
SandersSBarnettACorrea-VelezICoulthardMDoustJ.Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J Pediatr. 2008;153(4):570-574.e3. doi:10.1016/j.jpeds.2008.04.023.
8.
ColombetIPouchotJKronzV, et al. Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice. Am J Med. 2010;123(9):863.e7-863.e13. doi:10.1016/j.amjmed.2010.04.021.
9.
VardiabasisNVSchlechterJA.Definitive diagnosis of children presenting to a pediatric emergency department with fever and extremity pain. J Emerg Med. 2017;53(3):306-312. doi:10.1016/j.jemermed.2017.05.030.
10.
PääkkönenMKallioMJTKallioPEPeltolaH.Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010;468(3):861-866. doi:10.1007/s11999-009-0936-1.
11.
ReesCALimJWestbrookAL, et al. Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low-and middle-income countries. BMJ Paediatr Open. 2023;7(1):e001627. doi:10.1136/bmjpo-2022-001627.
12.
AssasiNBlackhouseGCampbellK, et al. Comparative Value of Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Testing in Combination Versus Individually for the Diagnosis of Undifferentiated Patients with Suspected Inflammatory Disease or Serious Infection: A Systematic Review and Economic Analysis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015.Accessed July 23, 2024. http://www.ncbi.nlm.nih.gov/books/NBK333365/
13.
BrayCBellLNLiangH, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317-321.
14.
SamsudinIVasikaranSD.Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017;38(2):59-68.
15.
McMichaelBSNickelAJChristensenEW, et al. Discriminative accuracy of procalcitonin and traditional biomarkers in pediatric acute musculoskeletal infection. Pediatr Emer Care. 2021;37(12):e1220-e1226. doi:10.1097/PEC.0000000000001978.
16.
Arredondo MonteroJBardají PascualCAntonaGRos BrionesRLópez-AndrésNMartín-CalvoN. The BIDIAP index: a clinical, analytical and ultrasonographic score for the diagnosis of acute appendicitis in children. Pediatr Surg Int. 2023;39(1):175. doi:10.1007/s00383-023-05463-5.
17.
GüngörAGöktuğAYaradılmışRM, et al. Utility of the systemic immune-inflammation index to predict serious bacterial infections in infants with fever without a source. Postgrad Med. 2022;134(7):698-702. doi:10.1080/00325481.2022.2091373.
18.
NicoarăDMMunteanuAIScutcaAC, et al. Evaluating the diagnostic performance of systemic immune-inflammation index in childhood inflammatory arthritis: a focus on differentiating juvenile idiopathic arthritis from reactive arthritis. Biomedicines. 2023;12(1):65. doi:10.3390/biomedicines12010065.
19.
Arredondo MonteroJPérez RiverosBPMartín-CalvoN.Diagnostic performance of total platelet count, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for overall and complicated pediatric acute appendicitis: a systematic review and meta-analysis. Surg Infect (Larchmt). 2023;24(4):311-321. doi:10.1089/sur.2023.013.
20.
BaiLGongPJiaX, et al. Comparison of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for the diagnosis of neonatal sepsis: a systematic review and meta-analysis. BMC Pediatr. 2023;23(1):334. doi:10.1186/s12887-023-04094-y.
21.
OkuyanOElgormusYDumurSSayiliUUzunH.New generation of systemic inflammatory markers for respiratory syncytial virus infection in children. Viruses. 2023;15(6):1245. doi:10.3390/v15061245.
22.
BoccuzziEBuonsensoDFerroV, et al. The osteoarticular infection in a pediatric emergency setting: a challenging diagnosis. Pediatr Emer Care. 2020;36(2):e108-e114. doi:10.1097/PEC.0000000000002045.
23.
AkinkugbeOStewartCMcKennaC.Presentation and investigation of pediatric bone and joint infections in the pediatric emergency department. Pediatr Emer Care. 2019;35(10):700-704. doi:10.1097/PEC.0000000000001431.
24.
PantellRHRobertsKBAdamsWG, et al. Clinical practice guideline: evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148(2):e2021052228. doi:10.1542/peds.2021-052228.
25.
Rivera-SepulvedaAMaulTDongK, et al. Effect of the COVID-19 pandemic on the pediatric emergency department flow. Disaster Med Public Health Prep. 2021;17:e83. doi:10.1017/dmp.2021.355.
26.
Day-LewisMBerbertLBakerADionneANewburgerJWSonMBF. Updated case definition of MIS-C and implications for clinical care. Pediatrics. 2024;153(2):e2023063259. doi:10.1542/peds.2023-063259.
27.
SillsM.Inpatient capacity at children’s hospitals during pandemic (H1N1) 2009 outbreak, United States. Emerg Infect Dis. 2011;17(9):1685-1691. doi:10.3201/eid1709.101950.
28.
NewburgerJWTakahashiMGerberMA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation. 2004;110(17):2747-2771. doi:10.1161/01.CIR.0000145143.19711.78.
Ben-ZviLSebagDIzhakiGKatzEBernfeldB.Diagnosis and management of infectious arthritis in children. Curr Infect Dis Rep. 2019;21(7):23. doi:10.1007/s11908-019-0678-5.
31.
GillPSandersJE.Emergency department management of pediatric septic arthritis and osteomyelitis. Pediatr Emerg Med Pract. 2019;16(12):1-24.
32.
WoodsCRBradleyJSChatterjeeA, et al. Clinical practice guideline by the pediatric infectious diseases society and the infectious diseases society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. J Pediatric Infect Dis Soc. 2021;10(8):801-844. doi:10.1093/jpids/piab027.
33.
StephanAMPlattSLevineDA, et al. A novel risk score to guide the evaluation of acute hematogenous osteomyelitis in children. Pediatrics. 2024;153(2):e2023063153. doi:10.1542/peds.2023-063153.
34.
PicoraroJAMooreHLeLeikoNS.Inflammatory bowel disease: an update. Pediatr Rev. 2023;44(3):139-152. doi:10.1542/pir.2022-005750.
TurnerDMackDRHyamsJ, et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? a systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis. 2011;5(5):423-429. doi:10.1016/j.crohns.2011.05.003.
GewitzMHBaltimoreRSTaniLY, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American heart association. Circulation. 2015;131(20):1806-1818. doi:10.1161/CIR.0000000000000205.
39.
WatsonJJonesHEBanksJWhitingPSalisburyCHamiltonW.Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy. Br J Gen Pract. 2019;69(684):e462-e469. doi:10.3399/bjgp19X704309.
40.
SimonLGauvinFAmreDKSaint-LouisPLacroixJ.Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-217. doi:10.1086/421997.
41.
LapićIPadoanABozzatoDPlebaniM.Erythrocyte sedimentation rate and c-reactive protein in acute inflammation. Am J Clin Pathol. 2020;153(1):14-29. doi:10.1093/ajcp/aqz142.
42.
RehmaniRAmanullahS.Analysis of blood tests in the emergency department of a tertiary care hospital. Postgrad Med J. 1999;75(889):662-666. doi:10.1136/pgmj.75.889.662.
43.
MarkhamJLThurmCWHallM, et al. Variation in early inflammatory marker testing for infection-related hospitalizations in children. Hosp Pediatr. 2020;10(10):851-858. doi:10.1542/hpeds.2020-0114.
44.
DikJHPoelmanRFriedrichAWNiestersHGMRossenJWASinhaB.Integrated stewardship model comprising antimicrobial, infection prevention, and diagnostic stewardship (AID Stewardship). J Clin Microbiol. 2017;55(11):3306-3307. doi:10.1128/JCM.01283-17.
45.
Paydar-DarianNKimiaAAMonuteauxMC, et al. C-reactive protein or erythrocyte sedimentation rate results reliably exclude invasive bacterial infections. Am J Emerg Med. 2019;37(8):1510-1515. doi:10.1016/j.ajem.2018.11.011.
46.
DharmapalanDYewaleV.C-reactive protein in pediatric infectious diseases. Pediatr Infect Dis J. 2012;4(3):137-139. doi:10.1016/j.pid.2012.08.002.
47.
DikJWHPoelmanRFriedrichAW, et al. An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future Microbiol. 2016;11(1):93-102. doi:10.2217/fmb.15.99.
48.
LitaoMKSKamatD.Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann. 2014;43(10):417-420. doi:10.3928/00904481-20140924-10.
49.
Choosing Wisely Campaign. American society of clinical pathology recommendations. Accessed July 1, 2023. https://metroplus.org/
50.
ChoHJTalledoJAlaievD, et al. Choosing wisely and reducing the simultaneous ordering of erythrocyte sedimentation rate and C-reactive protein testing in a large safety net system. Am J Clin Pathol. 2023;160(6):585-592. doi:10.1093/ajcp/aqad093.
51.
BartlettKJVoAPRueckertJ, et al. Promoting appropriate utilisation of laboratory tests for inflammation at an academic medical centre. BMJ Open Qual. 2020;9(1):e000788. doi:10.1136/bmjoq-2019-000788.
52.
WindhamAKWhittedMBrimhallB, et al. Adherence to choosing wisely campaign guidelines at three health systems. Am J Clin Pathol. 2021;156(suppl 1):S119-S119. doi:10.1093/ajcp/aqab191.254.
53.
GottheilSKhemaniECopleyK, et al. Reducing inappropriate ESR testing with computerized clinical decision support. BMJ Qual Improv Report. 2016;5(1):1-4. doi:10.1136/bmjquality.u211376.w4582.
54.
FatemiYPolskyTBurnsJ, et al. Reducing erythrocyte sedimentation rate ordering: de-implementation and diagnostic stewardship. Hosp Pediatr. 2024;14(8):658-665. doi:10.1542/hpeds.2023-007642.
55.
BairdGS.The choosing wisely initiative and laboratory test stewardship. Diagnosis. 2019;6(1):15-23. doi:10.1515/dx-2018-0045.
56.
MorganDJMalaniPDiekemaDJ.Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA. 2017;318(7):607. doi:10.1001/jama.2017.8531.
57.
FabreVDavisADiekemaDJ, et al. Principles of diagnostic stewardship: a practical guide from the society for healthcare epidemiology of America diagnostic stewardship task force. Infect Control Hosp Epidemiol. 2023;44(2):178-185. doi:10.1017/ice.2023.5.
58.
KarbasianFDorrani BakhshAMirrahimiBArminS.Appropriateness of antibiotic prescribing in the emergency department of Mofid children’s hospital: a retrospective cross-sectional study. Arch Pediatr Infect Dis. 2023;11(4):e136149. doi:10.5812/apid-136149.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
